CIK 0001714899
- Large accelerated filer
Denali Therapeutics Inc.
Sign in to watch- Ticker
- DNLI
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 463872213
- Phone
- +1 650-866-8547
- Business address
- 161 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA, 94080
- 4 Open-market sale Director sold 3,237 shares at an average $60.11 ($194,589)
- 4 Open-market sale President and CEO sold 18,333 shares at an average $58.64 ($1,075,102)
- 4 Open-market sale Director sold 1,666 shares at an average $62.15 ($103,538)
- 4 Open-market sale COO and Secretary sold 10,000 shares at an average $56.09 ($560,901)
- 4 Open-market sale Director sold 50,000 shares at an average $56.62 ($2,831,071)
- 4 Open-market sale President and CEO sold 18,334 shares at an average $56.60 ($1,037,684)
- 4 Open-market sale Director sold 1,666 shares at an average $56.42 ($93,992)
- 4 Open-market sale Chief Medical Officer sold 2,822 shares at $54.62 ($154,126)
- 4 Open-market sale CFO and Treasurer sold 50,000 shares at an average $61.89 ($3,094,563)
- 4 Open-market sale COO and Secretary sold 10,000 shares at an average $61.02 ($610,171)
- 4 Open-market sale Director sold 1,666 shares at an average $61.61 ($102,641)
- 4 Open-market sale Chief Medical Officer sold 7,092 shares at an average $66.38 ($470,741)
- 4 Open-market sale Director sold 100,000 shares at an average $66.22 ($6,622,207)
- 4 Open-market sale President and CEO sold 18,334 shares at an average $66.35 ($1,216,551)
- 4 Open-market sale CFO and Treasurer sold 50,000 shares at an average $65.09 ($3,254,710)
- 4 Open-market sale 10% owner sold 2,216,798 shares at $65.00 ($144,091,870)
- 4 Open-market sale Chief Medical Officer sold 3,156 shares at an average $70.33 ($221,972)
- 4 Open-market sale COO and Secretary sold 3,047 shares at an average $70.35 ($214,341)
- 4 Open-market sale CFO and Treasurer sold 3,035 shares at an average $70.34 ($213,480)
- 4 Open-market sale President and CEO sold 9,473 shares at an average $70.30 ($665,984)
Page 13 of 22 · 436 filings